Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose

* Context.--Myocarditis in adolescents has been diagnosed clinically following the administration of the second dose of an mRNA vaccine for coronavirus disease 2019 (COVID-19). Objective.--To examine the autopsy microscopic cardiac findings in adolescent deaths that occurred shortly following admini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of pathology & laboratory medicine (1976) 2022-08, Vol.146 (8), p.925-929
Hauptverfasser: Gill, James R, Tashjian, Randy, Duncanson, Emily
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:* Context.--Myocarditis in adolescents has been diagnosed clinically following the administration of the second dose of an mRNA vaccine for coronavirus disease 2019 (COVID-19). Objective.--To examine the autopsy microscopic cardiac findings in adolescent deaths that occurred shortly following administration of the second Pfizer-BioNTech COVID-19 dose to determine if the myocarditis described in these instances has the typical histopathology of myocarditis. Design.--Clinical and autopsy investigation of 2 teenage boys who died shortly following administration of the second Pfizer-BioNTech COVID-19 dose. Results.--The microscopic examination revealed features resembling a catecholamine-induced injury, not typical myocarditis pathology. Conclusions.--The myocardial injury seen in these postvaccine hearts is different from typical myocarditis and has an appearance most closely resembling a catecholamine-mediated stress (toxic) cardiomyopathy. Understanding that these instances are different from typical myocarditis and that cytokine storm has a known feedback loop with catecholamines may help guide screening and therapy. (Arch Pathol Lab Med. 2022;146:925-929; doi: 10.5858/arpa.2021-0435-SA)
ISSN:0003-9985
1543-2165
1543-2165
DOI:10.5858/arpa.2021-0435-SA